US Compounding Recalls Dapiprazole Ophthalmic Vials Due to Sterility Concerns
US Compounding Inc is recalling 2,984 bottles of compounded Dapiprazole ophthalmic vials nationwide due to deficient practices that may impact sterility assurance.
- Product
- Dapiprazole (Diluent+Powder) 0.5% in 5 mL vial, For topical ophthalmic use, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-0201-99
- Category
- Drug
- Distribution
- Distributed nationwide